PHASE-II CLINICAL-TRIAL OF GM2-KLH QS-21 (GMK) VACCINE IN PATIENTS WITH MALIGNANT-MELANOMA/

Authors
ISRAEL RJ CHAPMAN P MYERS M HAMILTON WB CHANG CH ZHAN C MORRISSEY D LIVINGSTON P
Citation
Rj. Israel et al., PHASE-II CLINICAL-TRIAL OF GM2-KLH QS-21 (GMK) VACCINE IN PATIENTS WITH MALIGNANT-MELANOMA/, Annals of oncology, 9, 1998, pp. 322-322
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
322 - 322
Database
ISI
SICI code
0923-7534(1998)9:<322:PCOGQ(>2.0.ZU;2-R